These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Indications and use of omeprazole in esophago-gastro-duodenal diseases]. Martín de Argila C, Boixeda de Miquel D, Moreira Vicente V, García Plaza A. Rev Clin Esp; 1999 Nov 04; 199(11):729-39. PubMed ID: 10638238 [No Abstract] [Full Text] [Related]
15. H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases. Lamers CB. Digestion; 1989 Nov 04; 44 Suppl 1():92-5. PubMed ID: 2691316 [Abstract] [Full Text] [Related]
16. Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis. Bium AL. Digestion; 1989 Nov 04; 44 Suppl 1():87-91. PubMed ID: 2691314 [Abstract] [Full Text] [Related]
17. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers. Meijer JL, Jansen JB, Lamers CB. Digestion; 1989 Nov 04; 44 Suppl 1():31-9. PubMed ID: 2575060 [Abstract] [Full Text] [Related]